Clinical Trial Update: Duloxetine in Inflammatory Bowel Diseases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of duloxetine for inflammatory bowel diseases is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: University of Pennsylvania | Conditions: Inflammatory Bowel Diseases | Phase 2 | Status: NOT_YET_RECRUITING